Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin (Q31372845)

1 July 2017

title

Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin (English)

1 reference

methicillin-resistant Staphylococcus aureus

1 July 2017

main subject

0 references

Staphylococcus aureus

1 reference

Eckart RE

1

1 reference

1 July 2017

Hospenthal DR

series ordinal

2

1 reference

1 July 2017

Fishbain JT

series ordinal

3

1 reference

1 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

1 July 2017

1 reference

1 July 2017

volume

20

1 reference

1 July 2017

issue

5

1 reference

1 July 2017

page(s)

589-592

1 reference

Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992.

1 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Community-acquired methicillin-resistant Staphylococcus aureus right-sided infective endocarditis in a non-addict patient with ventricular septal defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Pharmacokinetics and pharmacodynamics of newer fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.589.35156

10.1592/PHCO.20.6.589.35156

21 January 2018

Identifiers

DOI

1 reference

1 July 2017

1 reference